Literature DB >> 12704597

Cigarette smoking and diabetes.

Björn Eliasson1.   

Abstract

Smokers are insulin resistant, exhibit several aspects of the insulin resistance syndrome, and are at an increased risk for type 2 diabetes. Prospectively, the increased risk for diabetes in smoking men and women is around 50%. Many patients with type 1 and type 2 diabetes mellitus are at risk for micro- and macrovascular complications. Cigarette smoking increases this risk for diabetic nephropathy, retinopathy, and neuropathy, probably via its metabolic effects in combination with increased inflammation and endothelial dysfunction. This association is strongest in type 1 diabetic patients. The increased risk for macrovascular complications, coronary heart disease (CHD), stroke, and peripheral vascular disease, is most pronounced in type 2 diabetic patients. The development of type 2 diabetes is another possible consequence of cigarette smoking, besides the better-known increased risk for cardiovascular disease. In diabetes care, smoking cessation is of utmost importance to facilitate glycemic control and limit the development of diabetic complications. Copyright 2003, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12704597     DOI: 10.1053/pcad.2003.00103

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  80 in total

Review 1.  Drug therapy for chronic idiopathic axonal polyneuropathy.

Authors:  Janna Warendorf; Alexander Fje Vrancken; Ivo N van Schaik; Richard Ac Hughes; Nicolette C Notermans
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

2.  Smoking is associated with an increased risk of type 2 diabetes but a decreased risk of autoimmune diabetes in adults: an 11-year follow-up of incidence of diabetes in the Nord-Trøndelag study.

Authors:  S Carlsson; K Midthjell; V Grill
Journal:  Diabetologia       Date:  2004-11-19       Impact factor: 10.122

Review 3.  Biomarkers to assess the utility of potential reduced exposure tobacco products.

Authors:  Dorothy K Hatsukami; Neal L Benowitz; Stephen I Rennard; Cheryl Oncken; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2006-08       Impact factor: 4.244

4.  Introducing tobacco cessation in developing countries: an overview of Project Quit Tobacco International.

Authors:  M Nichter
Journal:  Tob Control       Date:  2006-06       Impact factor: 7.552

5.  High-dose but not low-dose mainstream cigarette smoke suppresses allergic airway inflammation by inhibiting T cell function.

Authors:  Thomas H Thatcher; Randi P Benson; Richard P Phipps; Patricia J Sime
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-06-20       Impact factor: 5.464

6.  Perceptions and Prevalence of Alcohol and Cigarette Use Among American Indian Adults With Type 2 Diabetes.

Authors:  Melissa L Walls; Dane Hautala; Miigis Gonzalez; Brenna Greenfield; Benjamin D Aronson; Emily Onello
Journal:  Clin Diabetes       Date:  2019-07

Review 7.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

8.  Chronic illness and smoking cessation.

Authors:  Kushal Patel; David Schlundt; Celia Larson; Hong Wang; Anne Brown; Margaret Hargreaves
Journal:  Nicotine Tob Res       Date:  2009-06-10       Impact factor: 4.244

9.  Antihyperlipidemic effect of bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione, a curcumin analog, on nicotine and streptozotocin treated rats.

Authors:  Bandugula Venkata Reddy; J Sivagama Sundari; Elumalai Balamurugan; Venugopal Padmanabhan Menon
Journal:  Mol Cell Biochem       Date:  2009-09-30       Impact factor: 3.396

10.  Chronic smoking and the BOLD response to a visual activation task and a breath hold task in patients with schizophrenia and healthy controls.

Authors:  Lee Friedman; Jessica A Turner; Hal Stern; Daniel H Mathalon; Liv C Trondsen; Steven G Potkin
Journal:  Neuroimage       Date:  2008-01-05       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.